Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minodronic acid vs alendronate in postmenopausal osteoporosis
CTR20140299Phase 2Active
- Sponsor
- Tianjin Hankang Pharmaceutical Biotechnology
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minodronic acid in osteoporosis, sponsored by Tianjin Hankang Pharmaceutical Biotechnology. Started Jun 2014; status: active.
02
Drugs
minodronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on CTR20140299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140299.